NEWARK, NJ, March 10, 2020 – The New Jersey Innovation Institute’s (NJII) Biopharma division is pleased to announce the formation of their advisory committee which includes experts from across the industry. The committee will meet quarterly and …
Read more
It is evident that the cell and gene therapy sectors are growing faster than the field of available talent, pressuring start-ups and established players alike. That was the key driver for the Talent Development Ideation …
Read more
NEWARK, NJ, October 8, 2019 – Donald H. Sebastian, NJII CEO and president, Tomas Gregorio, senior vice president NJII healthcare division and Haro Hartounian, senior executive director NJII biotechnology and pharmaceutical innovation have been named to …
Read more
NEWARK, NJ, March 19, 2019 – New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) Corporation, has signed an Industry Participation Agreement with Pall Corporation (Pall) to support the development of its Biopharmaceutical …
Read more